Polarean Imaging (POLX) , the medical-imagine company with a proprietary drug-device combination product for the MRI market, has delivered and installed its latest research unit from the University of British Columbia (UBC).
The order, a 9820 Xenon Polariser system, will be stored initially at the university’s children’s hospital, a major paediatric research and teaching hospital.
Its placing at the children’s hospital will be temporary whilst construction proceeds for the system’s ultimate site at UBC.
Enabled via a grant from the Canada Foundation for Innovation, this system will support their paediatric pulmonary disease research programme using hyperpolarised gas imaging.
Following delivery of this order, the total number of the Company's polarisers that are either installed or on order is 25.Richard Hullihen, CEO of Polarean, said the polariser, a platform for researchers at the children’s hospital, will develop the group’s “paediatric research cluster” which includes Cincinnati Children's Hospital Medical Center and Toronto SickKids Hospital.
“We look forward to enabling their new discoveries in these critical projects and we welcome UBC to the group," he added.
Follow News & Updates from Polarean Imaging: